Molecular dynamics studies of caspase-3

Biophysical Journal

Volumn 84, Issue 4, 2003, Pages 2207-2215

  Sulpizi, M ^a   Rothlisberger, U ^a   Carloni, P ^b  

^a EPFL   (Switzerland)

^b SISSA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; DIMER;

AMINO TERMINAL SEQUENCE; AQUEOUS SOLUTION; ARTICLE; CORRELATION ANALYSIS; ELECTRICITY; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME CONFORMATION; ENZYME KINETICS; ENZYME STABILITY; ENZYME SUBSTRATE; MICHAELIS CONSTANT; MOLECULAR DYNAMICS; MOLECULAR MECHANICS; PROTEIN INTERACTION; TRANSPORT KINETICS;

EID: 0037380948     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3495(03)75026-7     Document Type: Article

References (64)

1. Amadei, A., A. B. Linssen, and H. J. Berendsen. 1993. Essential dynamics of proteins. Proteins. 17:412-425.
2. Berendsen, H. J. C., J. P. M. Postma, W. F. van Gunsteren, A. Di Nola, and J. R. Haak. 1984. J. Chem. Phys. 81:3684-3690.
3. Blanchard, H., L. Kodandapani, P. R. Mittl, S. D. Marco, J. F. Krebs, J. C. Wu, K. J. Tomaselli, and M. G. Grutter. 1999. The three-dimensional structure of caspase-8: an initiator enzyme in apoptosis. Struct. Fold. Des. 7:1125-1133.
4. Brinen, L. S., E. Hansell, J. Cheng, W. R. Roush, J. H. McKerrow, and R. J. Fletterick. 2000. A target within the target: probing cruzain's P1' site to define structural determinants for the Chagas' disease protease. Struct. Fold. Des. 8:831-840.
5. Chillemi, G., M. Falconi, A. Amadei, G. Zimatore, A. Desideri, and A. Di Nola. 1997. The essential dynamics of Cu, Zn superoxide dismutase: suggestion of intersubunit communication. Biophys. J. 73:1007-1018.
6. Cohen, G. M. 1997. Caspases: the executioners of apoptosis. Biochem. J. 326:1-16.
7. Colussi, P. A., N. L. Harvey, L. M. Shearwin-Whyatt, and S. Kumar. 1998. Conversion of procaspase-3 to an autoactivating caspase by fusion to the caspase-2 prodomain. J. Biol. Chem. 273:26566-26570.
8. Coulombe, R., P. Grochulski, J. Sivaraman, R. Menard, J. S. Mort, and M. Cygler. 1996. Structure of human procathepsin L reveals the molecular basis of inhibition by the prosegment. EMBO J. 15:5492-5503.
9. de Groot, B. L., D. M. van Aalten, A. Amadei, and H. J. Berendsen. 1996. The consistency of large concerted motions in proteins in molecular dynamics simulations. Biophys. J. 71:1707-1713.
10. Drenth, J., J. N. Jansonius, R. Koekoek, H. M. Swen, and B. G. Wolthers. 1968. Structure of papain. Nature. 218:929-932.
11. Enari, M., H. Sakahira, H. Yokoyama, K. Okawa, A. Iwamatsu, and S. Nagata. 1998. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature. 391:43-50.
12. Fengler, A., and W. Brandt. 1998. Three-dimensional structures of the cysteine proteases cathepsins K and S deduced by knowledge-based modelling and active site characteristics. Protein Eng. 11:1007-1013.
13. Fersht, A. 1997. Enzyme Structure and Mechanism. W. H. Freeman and Co., New York.
14. Garcia, A. E., and G. Hummer. 1999. Conformational dynamics of cytochrome c: correlation to hydrogen exchange. Proteins. 36:175-191.
15. Gillmor, S. A., C. S. Craik, and R. J. Fletterick. 1997. Structural determinants of specificity in the cysteine protease cruzain. Protein Sci. 6:1603-1611.
16. Gilson, M. K., and B. Honig. 1988. Calculation of the total electrostatic energy of a macromolecular system: solvation energies, binding energies, and conformational analysis. Proteins. 4:7-18.
17. Guncar, G., M. Podobnik, J. Pungercar, B. Strukelj, V. Turk, and D. Turk. 1998. Crystal structure of porcine cathepsin H determined at 2.1 Å resolution: location of the mini-chain C-terminal carboxyl group defines cathepsin H aminopeptidase function. Structure. 6:51-61.
18. Guncar, G., G. Pungercic, I. Klemencic, V. Turk, and D. Turk. 1999. Crystal structure of MHC class H-associated p41 Ii fragment bound to cathepsin L reveals the structural basis for differentiation between cathepsins L and S. EMBO J. 18:793-803.
19. Huang, Y., Y. C. Park, R. L. Rich, D. Segal, D. G. Myszka, and H. Wu. 2001. Structural basis of caspase inhibition by XIAP: differential roles of the linker versus the BIR domain. Cell. 104:781-790.
20. Hunenberger, P. 2000. Optimal charge-shaping functions for the particle-particle-particle-mesh (P3M) method for computing electrostatic interactions in molecular simulations. J. Chem. Phys. 113:10464-10476.
21. Jia, Z., S. Hasnain, T. Hirama, X. Lee, J. S. Mort, R. To, and C. P. Huber. 1995. Crystal structures of recombinant rat cathepsin B and a cathepsin B- inhibitor complex. Implications for structure-based inhibitor design. J. Biol. Chem. 270:5527-5533.
22. Johnston, S. C., C. N. Larsen, W. J. Cook, K. D. Wilkinson, and C. P. Hill. 1997. Crystal structure of a deubiquitinating enzyme (human UCH-L3) at 1.8 Å resolution. EMBO J. 16:3787-3796.
23. Johnston, S. C., S. M. Riddle, R. E. Cohen, and C. P. Hill. 1999. Structural basis for the specificity of ubiquitin C-terminal hydrolases. EMBO J. 18:3877-3887.
24. Jordan, J., M. F. Galindo, V. Cena, and C. Gonzalez-Garcia. 2000. Cysteine proteinase and neurodegeneration. Rev. Neurol. 31:333-340.
25. Kamphuis, I. G., K. H. Kalk, M. B. Swarte, and J. Drenth. 1984. Structure of papain refined at 1.65 Å resolution. J. Mol. Biol. 179:233-256.
26. Kaufmann, S. H., and G. J. Gores. 2000. Apoptosis in cancer: cause and cure. Bioessays. 22:1007-1017.
27. Lazebnik, Y. A., S. H. Kaufmann, S. Desnoyers, G. G. Poirier, and W. C. Eamshaw. 1994. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature. 371:346-347.
28. Leach, A. 1996. Molecular Modelling, Principles and Applications. Longman, Harlow, UK.
29. Lee, D., S. A. Long, J. L. Adams, G. Chan, K. S. Vaidya, T. A. Francis, K. Kikly, J. D. Winkler, C. M. Sung, C. Debouck, S. Richardson, M. A. Levy, W. E. DeWolf, Jr., P. M. Keller, T. Tomaszek, M. S. Head, M. D. Ryan, R. C. Haltiwanger, P. H. Liang, C. A. Janson, P. J. McDevitt, K. Johanson, N. O. Concha, W. Chan, S. S. Abdel-Meguid, A. M. Badger, M. W. Lark, D. P. Nadeau, L. J. Suva, M. Gowen, and M. E. Nuttall. 2000. Potent and selective nonpeptide inhibitors of caspases 3 and 7 inhibit apoptosis and maintain cell functionality. J. Biol. Chem. 275:16007-16014.
30. Lindahl, E., B. Hess, and D. van der Spoel. 2001. Gromacs 3.0: a package for molecular simulation and trajectory analysis. J. Mol. Mod. 7:306-317.
31. Liu, X., H. Zou, C. Slaughter, and X. Wang. 1997. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell. 89:175-184.
32. Mittl, P. R., S. Di Marco, J. F. Krebs, X. Bai, D. S. Karanewsky, J. P. Priestle, K. J. Tomaselli, and M. G. Grütter. 1997. Structure of recombinant human CPP32 in complex with the tetrapeptide acetyl-Asp-Val-Ala-Asp fluoromethyl ketone. J. Biol. Chem. 272:6539-6547.
33. Musil, D., D. Zucic, D. Turk, R. A. Engh, I. Mayr, R. Huber, T. Popovic, V. Turk, T. Towatari, N. Katunuma, et al. 1991. The refined 2.15 Å X-ray crystal structure of human liver cathepsin B: the structural basis for its specificity. EMBO J. 10:2321-2330.
34. Muzio, M., B. R. Stockwell, H. R. Stennicke, G. S. Salvesen, and V. M. Dixit. 1998. An induced proximity model for caspase-8 activation. J. Biol. Chem. 273:2926-2930.
35. Nicholson, D. W., A. Ali, N. A. Thomberry, J. P. Vaillancourt, C. K. Ding, M. Gallant, Y. Gareau, P. R. Griffin, M. Labelle, Y. A. Lazebnik, et al. 1995. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 376:37-43.
36. Okamoto, Y., H. Anan, E. Nakai, K. Morihira, Y. Yonetoku, H. Kurihara, H. Sakashita, Y. Terai, M. Takeuchi, T. Shibanuma, and Y. Isomura. 1999. Peptide based interleukin-1 beta converting enzyme (ICE) inhibitors: synthesis, structure activity relationships and crystallographic study of the ICE-inhibitor complex. Chem. Pharm. Bull. (Tokyo). 47:11-21.
37. Piana, S., P. Carloni, and M. Parrinello. 2002. Role of conformational fluctuations in the enzymatic reaction of HIV-1 protease. J. Mol. Biol. 319:567-83.
38. Porter, A. G., and R. U. Janicke. 1999. Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 6:99-104.
39. Radkiewicz, J., and C. Brooks. 2000. Protein dynamics in enzymatic catalysis: exploration of dihydrofolate reductase. J. Am. Chem. Soc. 122:225-231.
40. Rano, T. A., T. Timkey, E. P. Peterson, J. Rotonda, D. W. Nicholson, J. W. Becker, K. T. Chapman, and N. A. Thornberry. 1997. A combinatorial approach for determining protease specificities: application to interleukin-1beta converting enzyme (ICE). Chem. Biol. 4:149-155.
41. Renatus, M., H. R. Stennicke, F. L. Scott, R. C. Liddington, and G. S. Salvesen. 2001. Dimer formation drives the activation of the cell death protease caspase 9. Proc. Natl. Acad. Sci. USA. 98:14250-14255.
42. Riedl, S. J., M. Renatus, R. Schwarzenbacher, Q. Zhou, C. Sun, S. W. Fesik, R. C. Liddington, and G. S. Salvesen. 2001. Structural basis for the inhibition of caspase-3 by XIAP. Cell. 104:791-800.
43. Rotonda, J., D. W. Nicholson, K. M. Fazil, M. Gallant, Y. Gareau, M. Labelle, E. P. Peterson, D. M. Rasper, R. Ruel, J. P. Vaillancourt, N. A. Thornberry, and J. W. Becker. 1996. The three-dimensional structure of apopain/CPP32, a key mediator of apoptosis. Nat. Struct. Biol. 3:619-625.
44. Ryckaert, J. P., G. Ciccotti, and H. J. C. Berendsen. 1977. Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J. Comp. Phys. 23:327-341.
45. Salvesen, G. S., and V. M. Dixit. 1997. Caspases: intracellular signaling by proteolysis. Cell. 91:443-446.
46. Shimohama, S. 2000. Apoptosis in Alzheimer's disease - an update. Apoptosis. 5:9-16.
47. Stennicke, H. R., and G. S. Salvesen. 1997. Biochemical characteristics of caspases-3, -6, -7, and -8. J. Biol. Chem. 272:25719-25723.
48. Sulpizi, M., A. Laio, J. Vande Vondele, U. Rothlisberger, and P. Carloni. 2003. Proteins. In press.
49. Sussman, J. L., D. Lin, J. Jiang, N. O. Manning, J. Prilusky, O. Ritter, and E. E. Abola. 1998. Protein Data Bank (PDB): database of three-dimensional structural information of biological macromolecules. Acta Crystallogr. D Biol. Crystallogr. 54:1078-1084.
50. Talanian, R. V., K. D. Brady, and V. L. Cryns. 2000. Caspases as targets for anti-inflammatory and anti-apoptotic drug discovery. J. Med. Chem. 43:3351-3371.
51. Talanian, R. V., L. C. Dang, C. R. Ferenz, M. C. Hackett, J. A. Mankovich, J. P. Welch, W. W. Wong, and K. D. Brady. 1996. Stability and oligomeric equilibria of refolded interleukin-1beta converting enzyme. J. Biol. Chem. 271:21853-21858.
52. Thompson, S. K., S. M. Halbert, M. J. Bossard, T. A. Tomaszek, M. A. Levy, B. Zhao, W. W. Smith, S. S. Abdel-Meguid, C. A. Janson, K. J. D'Alessio, M. S. McQueney, B. Y. Amegadzie, C. R. Hanning, R. L. DesJarlais, J. Briand, S. K. Sarkar, M. J. Huddleston, C. F. Ijames, S. A. Carr, K. T. Games, A. Shu, J. R. Heys, J. Bradbeer, D. Zembryki, D. F. Veber, et al.1997. Design of potent and selective human cathepsin K inhibitors that span the active site. Proc. Natl. Acad. Sci. USA. 94:14249-14254.
53. Turk, D., M. Podobnik, T. Popovic, N. Katunuma, W. Bode, R. Huber, and V. Turk. 1995. Crystal structure of cathepsin B inhibited with CA030 at 2.0-A resolution: a basis for the design of specific epoxysuccinyl inhibitors. Biochemistry. 34:4791-4797.
54. van Gunsteren, W. F., S. R. Billeter, A. A. Eising, P. H. Hünenberger, P. K. H. C. Krüger, A. E. Mark, W. R. P. Scott, and I. G. Tironi. 1996. Biomolecular Simulation: The GROMOS96 Manual and User Guide. vdf Hochschulverlag AG, Zürich.
55. Ventimiglia, R., L. Lau, R. Kinloch, A. Hopkins, E. Karran, L. Petalidis, and R. Ward. 2001. Role of caspases in neuronal apoptosis. Drug Dev. Res. 52:525-533.
56. Walker, N. P., R. V. Talanian, K. D. Brady, L. C. Dang, N. J. Bump, C. R. Ferenz, S. Franklin, T. Ghayur, M. C. Hackett, L. D. Hammill, et al. 1994. Crystal structure of the cysteine protease interleukin-1 beta-converting enzyme: a (p20/p10)2 homodimer. Cell. 78:343-352.
57. Watt, W., K. A. Koeplinger, A. M. Mildner, R. L. Heinrikson, A. G. Tomasselli, and K. D. Watenpaugh. 1999. The atomic-resolution structure of human caspase-8, a key activator of apoptosis. Struct. Fold. Des. 7:1135-1143.
58. Wei, Y., T. Fox, S. P. Chambers, J. Sintchak, J. T. Coll, J. M. Golec, L. Swenson, K. P. Wilson, and P. S. Charifson. 2000. The structures of caspases-1, -3, -7 and -8 reveal the basis for substrate and inhibitor selectivity. Chem. Biol. 7:423-432.
59. Wilson, K. P., J. A. Black, J. A. Thomson, E. E. Kim, J. P. Griffith, M. A. Navia, M. A. Murcko, S. P. Chambers, R. A. Aldape, S. A. Raybuck, et al. 1994. Structure and mechanism of interleukin-1 beta converting enzyme. Nature. 370:270-275.
60. Xu, G., M. Cirilli, Y. Huang, R. L. Rich, D. G. Myszka, and H. Wu. 2001. Covalent inhibition revealed by the crystal structure of the caspase- 8/p35 complex. Nature. 410:494-497.
61. Yamamoto, A., K. Tomoo, T. Hara, M. Murata, K. Kitamura, and T. Ishida. 2000. Substrate specificity of bovine cathepsin B and its inhibition by CA074, based on crystal structure refinement of the complex. J. Biochem. (Tokyo). 127:635-643.
62. Yamashita, D. S., W. W. Smith, B. G. Zhao, C. A. Janson, T. A. Tomaszek, M. J. Bossard, M. A. Levy, H. J. Oh, T. J. Carr, S. K. Thompson, C. F. Ijames, S. A. Carr, M. McQueney, K. J. D'Alessio, B. Y. Amegadzie, C. R. Hanning, S. Abdelmeguid, R. L. DesJarlais, J. G. Gleason, and D. F. Veber. 1997. Structure and design of potent and selective cathepsin K inhibitors. J. Am. Chem. Soc. 119:11351-11352.
63. Yang, X., H. Y. Chang, and D. Baltimore. 1998. Autoproteolytic activation of pro-caspases by oligomerization. Mol. Cell. 1:319-325.
64. Zhao, B., C. A. Janson, B. Y. Amegadzie, K. D'Alessio, C. Griffin, C. R. Hanning, C. Jones, J. Kurdyla, M. McQueney, X. Qiu, W. W. Smith, and S. S. Abdel-Meguid. 1997. Crystal structure of human osteoclast cathepsin K complex with E-64. Nat. Struct. Biol. 4:109-111.